Having trouble viewing this email? View in your browser.

20 December 2016

Dear colleagues,

Researchers in Switzerland and Australia published a paper in PLOS where they question the validity of quantifying deaths due to antimicrobial resistance cited by the AMR report. They criticized that the authors failed to acknowledge the associated uncertainties regarding the incidence of infections, the prevalence of resistance and the attributable mortality. The authors conclude that detailed reliable data – comprehensive population-based surveillance data from low-, middle-, and high-income countries – is required to improve AMR control measures.

Season's greetings, your ESCMID communications editors

ESCMID Executive Office
Gerbergasse 14
4001 Basel
Phone +41 61 508 0150
Visit us on mastodon Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.